ImmusanT Competitors and Similar CompaniesClear all
ImmusanT's competitors and similar companies include Mesoblast and Translational Sciences.
 ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  Translational Sciences Translational Sciences is a biotechnology company that develops therapeutics for treating acute thrombotic cardiovascular diseases and ischemic stroke. | |
Founding Date | Founding Date 2010 | Founding Date 2004 | Founding Date 2007 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Phoenix, US HQ |
Employees | Employees 2 | Employees 73 | Employees N/A |
Funding | |||
Total funding raised | Total funding raised $ 72.8m | Total funding raised $ 56.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Mesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companyTranslational Sciences
HQ
Phoenix, US
Translational Sciences is a biotechnology company that develops therapeutics for treating acute thrombotic cardiovascular diseases and ischemic stroke.
View company